Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBC.1.6.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.6.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.4.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.4.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FQ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FQ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JB.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JB.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.3.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.144NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.144NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.288NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.288NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.249NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.249NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.378NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.378NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17507.2China
B.1.97NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.97NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FZ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FZ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.7.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.7.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.30.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.30.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.68NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.68NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CD.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CD.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.3 (Omicron)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.3 (Omicron)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.16.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.16.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.372NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.372NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.425NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.425NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.17 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.4.17 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used